𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of refractory thrombotic thrombocytopenic purpura using multimodality therapy including splenectomy and cyclosporine

✍ Scribed by Kenar D. Jhaveri; Abby Scheuer; Jules Cohen; Bruce Gordon


Book ID
116928821
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
134 KB
Volume
41
Category
Article
ISSN
1473-0502

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Cyclosporine therapy in refractory/relap
✍ Annamaria Nosari; Rosaria Redaelli; Teresa Maria Caimi; Gianni Mostarda; Enrica πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 289 KB πŸ‘ 2 views

To the editor: The interesting article by van Beers et al. states that functional studies does not offer clues as to the presence of mild pulmonary hypertension (PH) in patients with sickle cell disease (SCD) [1]. However, they did show that although not statistically significant, lung function find

Chronic relapsing thrombotic thrombocyto
✍ Pasquale, Donald; Vidhya, Rakesh; DaSilva, Karen; Tsan, Min-Fu; Lansing, Lawrenc πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 31 KB πŸ‘ 2 views

Relapsing thrombotic thrombocytopenic purpura (TTP) is a rare disorder with most individuals experiencing 1 to 5 relapses. We report a patient with 18 episodes of thrombotic thrombocytopenic purpura (TTP), the highest number of relapses thus far described. The last 11 episodes were treated with regi

Role of splenectomy in patients with ref
✍ Nicole A. Aqui; Steven H. Stein; Barbara A. Konkle; Charles S. Abrams; Frank J. πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 67 KB

## Abstract Thrombotic thrombocytopenic purpura (TTP) was once uniformly fatal. Therapeutic plasma exchange in combination with immunosuppressive and anti‐platelet agents, however, have resulted in improved survival rates of greater than 80% for patients with TTP. In spite of aggressive plasma exch